ANNISSA ROSSER: Open Payments
NPI 1285290536 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,805 in 161 payments from 19 companies in 2025. Trend: 2023 $2,978 · 2024 $3,077 · 2025 $3,805
Food & beverage: $3,797Education: $8
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $485 |
| Neurocrine BioSciences, Inc. | 20 | $447 |
| Janssen Pharmaceuticals, Inc | 17 | $421 |
| Otsuka America Pharmaceutical, Inc. | 15 | $404 |
| E.R. Squibb & Sons, L.L.C. | 15 | $293 |
| Alkermes, Inc. | 11 | $281 |
| Supernus Pharmaceuticals, Inc. | 14 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $234 |
| ABBVIE INC. | 8 | $218 |
| Corium, LLC | 9 | $144 |
Products named: INVEGA SUSTENNA, INGREZZA, AUSTEDO XR, ABILIFY MAINTENA, COBENFY, CAPLYTA, Qelbree, VRAYLAR.
Industry payments across MI — which companies pay providers there.
